Skip to main content

Advertisement

Table 5 Day specific prevalence and intensity of Og4C3 in the three drug groups.

From: Tolerability and efficacy of single dose albendazole, diethylcarbamazine citrate (DEC) or co-administration of albendazole with DEC in the clearance of Wuchereria bancroftiin asymptomatic microfilaraemic volunteers in Pondicherry, South India: a hospital-based study

Day Prevalence (%) Mean Intensity of OD valuesa
  Alb DEC Alb + DEC Alb DEC Alb + DEC
0 (pre-therapy) 94.7 88.2 94.1 0.49 (± 0.16) 0.39 (± 0.21) 0.47 (± 0.18)
7 94.7 87.5 88.2 0.47 (± 0.19) 0.40 (± 0.22) 0.44 (± 0.25)
360 15.8** 17.6** 17.6** 0.08** (± 0.17) 0.07** (± 0.15) 0.08** (± 0.15)
  1. a Data are mean ± SD. †P = non significant vs. day 0 (pre-therapy) **P = < 0.01 vs. day 0 (pre-therapy) Alb = albendazole, DEC = diethylcarbamazine citrate, Alb + DEC = albendazole + diethylcarbamazine citrate